The increase in the phosphorylation level of H2AX (p-γH2AX (Ser 139)) due to the LCS1269 treatment in all tested glioblastoma cells was used as a readout and confirmation of DNA damage (Figure 6A). The gene discussed is H2AX; the disease is glioblastoma.